Christopher M. Mulla
Impact in
-
- Diabetes Treatment and Management
- Diabetes Management and Research
- Hyperglycemia and glycemic control in critically ill and hospitalized patients
-
- Diet and metabolism studies
Papers in
-
- Diabetes Management and Research 6
- Diabetes Treatment and Management 5
- Hyperglycemia and glycemic control in critically ill and hospitalized patients 5
- Diet, Metabolism, and Disease 1
- Surgery 8
- Bariatric Surgery and Outcomes 6
- Pancreatic function and diabetes 1
- Co-authors
- Mary‐Elizabeth Patti (8 shared papers)Roeland J.W. Middelbeek (1 shared paper)Emmy Suhl (1 shared paper)Jonathan M. Dreyfuss (3 shared papers)Allison B. Goldfine (2 shared papers)David Pober (2 shared papers)Daniel K. Lee (1 shared paper)A. James Moser (1 shared paper)
- Journals
- The Journal of Clinical Endocrinology & Metabolism (2 papers)Current Diabetes Reports (2 papers)Obesity Surgery (2 papers)Diabetes Technology & Therapeutics (1 paper)Journal of Diabetes Science and Technology (1 paper)
- Partner nations
- United StatesGermanySouth Korea
In The Last Decade
Christopher M. Mulla
15 papers receiving 387 citations
Peers
Comparison fields: 5 of 50
- Endocrinology, Diabetes and Metabolism 189
- Physiology 166
- Surgery 276
- Pharmacy 22
- Gastroenterology 17
Countries citing papers authored by Christopher M. Mulla
This map shows the geographic impact of Christopher M. Mulla's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher M. Mulla with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher M. Mulla more than expected).
Fields of papers citing papers by Christopher M. Mulla
This network shows the impact of papers produced by Christopher M. Mulla. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher M. Mulla. The network helps show where Christopher M. Mulla may publish in the future.
Co-authors
The 25 scholars most cited alongside Christopher M. Mulla, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 110 | |
| 2 | 2017 | 69 | |
| 3 | 2019 | 37 | |
| 4 | 2019 | 31 | |
| 5 | 2016 | 30 | |
| 6 | 2021 | 26 | |
| 7 | 2018 | 26 | |
| 8 | 2020 | 14 | |
| 9 | 2019 | 12 | |
| 10 | 2019 | 11 | |
| 11 | 2015 | 8 | |
| 12 | 2009 | 8 | |
| 13 | 2012 | 6 | |
| 14 | 2014 | 5 | |
| 15 | 2024 | 2 |
About Christopher M. Mulla
Christopher M. Mulla is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery, Physiology, Molecular Biology and Epidemiology, having authored 15 papers that have together received 395 indexed citations. Recurring topics across this work include Diabetes Management and Research (6 papers), Bariatric Surgery and Outcomes (6 papers), Diabetes Treatment and Management (5 papers), Hyperglycemia and glycemic control in critically ill and hospitalized patients (5 papers), Diet and metabolism studies (4 papers), Metabolism, Diabetes, and Cancer (2 papers), Pancreatic function and diabetes (1 paper) and Diet, Metabolism, and Disease (1 paper). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (189 citations), Physiology (166 citations), Surgery (276 citations), Pharmacy (22 citations) and Gastroenterology (17 citations). Christopher M. Mulla has collaborated with scholars based in United States, Germany and South Korea. Frequent co-authors include Mary‐Elizabeth Patti, Roeland J.W. Middelbeek, Emmy Suhl, Jonathan M. Dreyfuss, Allison B. Goldfine, David Pober, Daniel K. Lee, A. James Moser, Brett Newswanger and Alessandra Storino. Their work appears in journals such as The Journal of Clinical Endocrinology & Metabolism, Current Diabetes Reports, Obesity Surgery, Diabetes Technology & Therapeutics and Journal of Diabetes Science and Technology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.